Cantargia Presents Nomination Committee Ahead of 2027 AGM

LUND, SE / ACCESS Newswire / October 29, 2026 / Cantargia AB (publ)(STO:CANTA), a clinical-stage biotechnology company focused on antibody-based therapeutics targeting IL1RAP, today provided notification that the Nomination Committee (NC) has been …